MFDS — authorised 8 November 2013
- Marketing authorisation holder: SUNOVION PHARMS INC
- Status: likely_approved
🇰🇷 Aptiom in South Korea
MFDS authorised Aptiom on 8 November 2013
Marketing authorisation
Aptiom in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in South Korea
Frequently asked questions
Is Aptiom approved in South Korea?
Yes. MFDS authorised it on 8 November 2013.
Who is the marketing authorisation holder for Aptiom in South Korea?
SUNOVION PHARMS INC holds the South Korean marketing authorisation.